Effectiveness and Safety of Trabeculectomy along with Amniotic Membrane Transplantation on Glaucoma: A Systematic Review
- PMID: 33133675
- PMCID: PMC7568795
- DOI: 10.1155/2020/3949735
Effectiveness and Safety of Trabeculectomy along with Amniotic Membrane Transplantation on Glaucoma: A Systematic Review
Abstract
Purpose: To determine the effectiveness and safety of trabeculectomy along with amniotic membrane transplantation (AMT) for glaucoma.
Methods: This systematic review was performed using RevMan 5.3. We searched PubMed, EMBASE, and the Cochrane Library and included studies published until September 2019. The treatment group included patients with AMT and trabeculectomy (group A), and the control group had only trabeculectomy (group B). We only included randomized controlled trials. The outcomes were intraocular pressure (IOP), complete success rate, number of antiglaucoma medications, and complications.
Results: Five studies, including 174 eyes (87 eyes in the AMT group and 87 eyes in the control group), were eligible in this review. The parameters had no significant difference in heterogeneity between the AMT and control groups preoperatively. In the AMT group, the mean IOP was significantly lower at 3 and 12 months after operation (P < 0.0001 and P = 0.02, respectively), while the number of complete successes in the AMT group was significantly higher at 6 and 12 months (P = 0.02 and P = 0.003, respectively) compared with the control group. Complications, including a flat anterior chamber and hyphema, appeared to be decreased in the AMT group compared to the control group (P = 0.02 and P = 0.02, respectively). No differences were observed in the number of antiglaucoma medications, hypotony, encapsulated bleb, or choroidal detachment.
Conclusion: Compared with only trabeculectomy, it is more efficient and safer to add AMT to trabeculectomy during glaucoma filtering surgery.
Copyright © 2020 Tian-yi Shen et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures






Similar articles
-
Filtering bleb structure associated with long-term intraocular pressure control after amniotic membrane-assisted trabeculectomy.Curr Eye Res. 2012 Mar;37(3):239-50. doi: 10.3109/02713683.2011.635403. Curr Eye Res. 2012. PMID: 22335812
-
The use of amniotic membrane in trabeculectomy for the treatment of primary open-angle glaucoma: a prospective study.Clin Ophthalmol. 2012;6:205-12. doi: 10.2147/OPTH.S27187. Epub 2012 Feb 2. Clin Ophthalmol. 2012. PMID: 22347791 Free PMC article.
-
Use of Amniotic Membrane in MMC-Augmented Trabeculectomy: A Retrospective Comparative Study.Clin Ophthalmol. 2021 Nov 27;15:4527-4533. doi: 10.2147/OPTH.S342593. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34866897 Free PMC article.
-
Trabeculectomy With Antimetabolite Agents for Normal Tension Glaucoma: A Systematic Review and Meta-Analysis.Front Med (Lausanne). 2022 Jun 28;9:932232. doi: 10.3389/fmed.2022.932232. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35836955 Free PMC article.
-
Cyclodestructive procedures for refractory glaucoma.Cochrane Database Syst Rev. 2019 Mar 10;3(3):CD012223. doi: 10.1002/14651858.CD012223.pub2. Cochrane Database Syst Rev. 2019. PMID: 30852841 Free PMC article.
Cited by
-
The Effect of Amniotic Membrane Transplantation on Trabeculectomy in Patients with Pseudoexfoliation Glaucoma.J Ophthalmol. 2022 Jul 30;2022:9355206. doi: 10.1155/2022/9355206. eCollection 2022. J Ophthalmol. 2022. PMID: 35942064 Free PMC article.
-
The developments in amniotic membrane transplantation in glaucoma and vitreoretinal procedures.Int Ophthalmol. 2023 May;43(5):1771-1783. doi: 10.1007/s10792-022-02570-5. Epub 2023 Jan 30. Int Ophthalmol. 2023. PMID: 36715957 Free PMC article. Review.
-
Management of experimental trabeculectomy filtering blebs via crosslinking of the scleral flap inhibited vascularization.Graefes Arch Clin Exp Ophthalmol. 2024 May;262(5):1507-1517. doi: 10.1007/s00417-023-06306-8. Epub 2023 Nov 9. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37943331
-
The Effect of Prostaglandin F2 Analog Treatment on the Immunoexpression of Fibrosis-Associated Factors in Patients with Glaucoma Undergoing Deep Sclerotomy.Int J Mol Sci. 2024 Nov 24;25(23):12618. doi: 10.3390/ijms252312618. Int J Mol Sci. 2024. PMID: 39684329 Free PMC article.
-
Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy.J Clin Med. 2023 May 22;12(10):3604. doi: 10.3390/jcm12103604. J Clin Med. 2023. PMID: 37240710 Free PMC article.
References
LinkOut - more resources
Full Text Sources